What is Cionic?
Cionic is fundamentally transforming the landscape of physical rehabilitation and human movement. By developing lightweight, durable bionic clothing, the company provides a sophisticated system that analyzes and augments human movement in real-time. The core of the Cionic platform lies in its advanced algorithmic architecture, which adapts dynamically to the specific mobility requirements of each user. Furthermore, by offering open APIs, Cionic empowers clinicians and researchers to develop bespoke therapeutic solutions, effectively democratizing access to high-end mobility assistance. This approach positions the company as a critical player in the health-tech sector, bridging the gap between traditional medical devices and consumer-accessible wearable technology.
How much funding has Cionic raised?
Cionic has raised a total of $25M across 1 funding round:
Series A
$25M
Series A (2023): $25M with participation from JobsOhio Growth Capital Fund, BlueRun Ventures, EPIC Ventures, LDV Capital, and Caffeinated Capital
Key Investors in Cionic
BlueRun Ventures
Launched in 1998, BlueRun Ventures functions as a venture capital fund. BlueRun Ventures is headquartered in Menlo Park, California, with offices in Beijing, Helsinki, Mumbai, Seoul, and Shanghai.
EPIC Ventures
EPIC Ventures is a venture capital firm that specializes in investing in innovative companies. Their portfolio includes a variety of startups across different industries, focusing on high-growth opportunities.
LDV Capital
LDV Capital is an investment firm that focuses on collaborating with deep tech teams developing businesses powered by visual technology, computer vision, machine learning, and artificial intelligence.
What's next for Cionic?
With the infusion of this major strategic investment, Cionic is poised to scale its operational footprint and deepen its clinical research initiatives. The company's roadmap likely involves expanding its product ecosystem to address a wider range of mobility impairments while refining its real-time data processing capabilities. As Cionic continues to integrate its technology into clinical workflows, the focus will shift toward achieving broader market penetration and establishing its bionic clothing as a standard of care in physical therapy. The strategic backing from its investor syndicate provides not only the necessary liquidity for R&D but also the institutional expertise required to navigate the complex regulatory and commercial landscapes of the medical device industry.
See full Cionic company page
